Dacarbazine recalls

The FDA has published 3 recalls involving Dacarbazine since 2014. The latest was reported on 3 Mar 2021. Most were for sterility. Infusion Options has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 3 Mar 2021

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 2 67%Class III 1 33%

Why dacarbazine is recalled

Sterility267%
Packaging Defects133%

Companies

By year

2021133%
2019133%
2014133%

All dacarbazine recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
3 Mar 2021Drug	CLASS II	Dacarbazine for Injection USP, 200 mg, Single Use Vial recalled	Teva Pharmaceuticals USA	Sterility	Nationwide
21 Aug 2019Drug	CLASS II	Dacarbazine 680 MG in NS; Dacarbazine 675 MG in NS recalled	Infusion Options	Sterility	NY
31 Dec 2014Drug	CLASS III	Dacarbazine, Injection, USP, 200mg, vials recalled by Hospira	Hospira	Packaging Defects	Nationwide

Should you stop taking Dacarbazine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.